Office of Commercialization & Ventures
Our mission is to bring the best partners into Joslin science and clinical innovation to create a lasting impact on diabetes care.
Partnering Science for Impact
Joslin Diabetes Center is the world's pre-eminent institution dedicated to building a future without diabetes by integrating cutting-edge research, innovative clinical care and patient education.
In order to realize its vision, Joslin continues to build bridges between science and industry in its ongoing quest for better treatments and ways to prevent and cure diabetes.
The Office of Commercialization & Ventures (OCV) is a business center of Joslin Diabetes Center focused on creating strategic relationships that will expand the reach of Joslin's research and clinical expertise and promote new products and services in diabetes, its complications and obesity.
Upcoming Events
News
News | Joslin Research
- Joslin Scientists Advance Understanding of Human Brown Adipose Tissue and Grow New Cells
- Joslin Study Reveals That Dietary Fat Can Affect Glucose Levels and Insulin Requirements for People with Type 1 Diabetes
- Joslin Scientists Discover Mechanism That Regulates Production of Energy-Burning Brown Fat
- Susan Bonner-Weir, Ph.D., Named American Association for the Advancement of Science Fellow
- Joslin Scientists Generate First Human Induced Pluripotent Stem Cells from Patients with Maturity Onset Diabetes of the Young

